CIK 0001588978
- Large accelerated filer
PROCEPT BioRobotics Corp
Sign in to watch- Ticker
- PRCT
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 260199180
- Phone
- +1 650-232-9832
- Business address
- 150 BAYTECH DRIVE, SAN JOSE, CA, 95134
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $114,707
- in 4 filings
Net −$114,707. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-09-16 | Waters Kevin EVP, CFO | Sale 10b5-1 | −6,623 | $81.96 | $543K | 114,473 |
| 2024-09-16 | Waters Kevin EVP, CFO | Sale 10b5-1 | −17,977 | $82.69 | $1.5M | 96,496 |
| 2024-09-16 | Waters Kevin EVP, CFO | Sale 10b5-1 | −400 | $83.35 | $33K | 96,096 |
| 2024-09-16 | Waters Kevin EVP, CFO | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −15,917 | $4.52 | $72K | 0 |
| 2024-09-16 | Waters Kevin EVP, CFO | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −9,083 | $4.56 | $41K | 44,160 |
| 2024-03-18 | Waters Kevin EVP, CFO | Sale | −1,024 | $48.83 | $50K | 102,149 |
| 2024-03-15 | Waters Kevin EVP, CFO | Exercise or conversion | +36,010 | $4.52 | $163K | 85,426 |
| 2024-03-15 | Waters Kevin EVP, CFO | Exercise or conversion | +17,747 | $4.56 | $81K | 103,173 |
| 2024-03-15 | Waters Kevin EVP, CFO | Exercise or conversion · Stock Option (Right to Buy) | −36,010 | 15,917 | ||
| 2024-03-15 | Waters Kevin EVP, CFO | Exercise or conversion · Stock Option (Right to Buy) | −17,747 | 53,243 | ||
| 2024-03-06 | Waters Kevin EVP, CFO | Grant or award | +13,275 | 46,798 | ||
| 2024-03-06 | Waters Kevin EVP, CFO | Grant or award · Stock Option (Right to Buy) | +11,563 | 11,563 | ||
| 2024-03-06 | Waters Kevin EVP, CFO | Grant or award | +19,328 | 52,851 | ||
| 2024-03-06 | Waters Kevin EVP, CFO | Sale | −3,435 | $46.67 | $160K | 49,416 |
| 2024-03-06 | Waters Kevin EVP, CFO | Grant or award · Stock Option (Right to Buy) | +16,835 | 16,835 | ||
| 2024-02-12 | Waters Kevin EVP, CFO | Exercise or conversion 10b5-1 | +22,349 | $4.52 | $101K | 55,872 |
| 2024-02-12 | Waters Kevin EVP, CFO | Sale 10b5-1 | −22,349 | $50.16 | $1.1M | 33,523 |
| 2024-02-12 | Waters Kevin EVP, CFO | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −22,349 | 51,927 | ||
| 2024-02-09 | Waters Kevin EVP, CFO | Exercise or conversion 10b5-1 | +28,677 | $4.52 | $130K | 62,200 |
| 2024-02-09 | Waters Kevin EVP, CFO | Sale 10b5-1 | −28,677 | $50.09 | $1.4M | 33,523 |
Page 2 of 4 · 68 trades